Inventor · disambiguated record
Dong Yu
Also filed as: YU DONG · YU DONG-SIK
67 granted patents·27 pending applications·1,617 citations·filing 1995–2025
99Inventor score
Files withIDERA PHARMACEUTICALS INC48HYBRIDON INC13AGRAWAL SUDHIR8KANDIMALLA EKAMBAR R6KANDIMALLA EKAMBAR5
Top patents by PatentIndex Score
94 records- 0198US8202850B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsAGRAWAL SUDHIR·Filed 2010·Granted Jun 19, 2012·60 cites·17 claims
- 0298US7812000B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·66 cites·18 claims
- 0398US7427405B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Sep 23, 2008·40 cites·7 claims
- 0498US7276489B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2002·Granted Oct 2, 2007·221 cites·22 claims
- 0597US7566702B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 28, 2009·28 cites·7 claims
- 0697US7498425B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 0797US7498426B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Mar 3, 2009·28 cites·7 claims
- 0896US9453228B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2015·Granted Sep 27, 2016·21 cites·24 claims
- 0996US8431544B1Compositions for inhibiting gene expression and uses thereofAGRAWAL SUDHIR·Filed 2010·Granted Apr 30, 2013·48 cites·16 claims
- 1096US7517862B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Apr 14, 2009·64 cites·9 claims
- 1196US7470674B2Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 30, 2008·48 cites·19 claims
- 1295US7407944B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 5, 2008·56 cites·6 claims
- 1395US7405285B2Immunostimulatory oligonucleotide multimersIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 29, 2008·35 cites·7 claims
- 1494US8426375B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Apr 23, 2013·25 cites·15 claims
- 1594US7262286B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2001·Granted Aug 28, 2007·42 cites·5 claims
- 1693US7632822B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 15, 2009·17 cites·7 claims
- 1792US8399423B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Mar 19, 2013·12 cites·12 claims
- 1892US8383598B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2008·Granted Feb 26, 2013·12 cites·13 claims
- 1992US8008267B2Stabilized immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 30, 2011·29 cites·16 claims
- 2092US7960362B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2008·Granted Jun 14, 2011·19 cites·6 claims
- 2192US7595305B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS·Filed 2005·Granted Sep 29, 2009·21 cites·7 claims
- 2291US8361986B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2011·Granted Jan 29, 2013·18 cites·6 claims
- 2391US7875594B2Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2008·Granted Jan 25, 2011·11 cites·7 claims
- 2491US7569554B2Synergistic treatment of cancer using immunomers in conjunction with therapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 4, 2009·23 cites·2 claims
- 2591US7354907B2Short immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Apr 8, 2008·38 cites·1 claims
- 2690US7884197B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 8, 2011·13 cites·5 claims
- 2790US7863250B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jan 4, 2011·9 cites·7 claims
- 2890US7749975B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 6, 2010·9 cites·8 claims
- 2989US8377898B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 19, 2013·15 cites·13 claims
- 3089US8357665B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2013·10 cites·15 claims
- 3189US8153608B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesAGRAWAL SUDHIR·Filed 2010·Granted Apr 10, 2012·9 cites·12 claims
- 3289US7776834B2Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Aug 17, 2010·12 cites·31 claims
- 3388US7833538B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Nov 16, 2010·6 cites·4 claims
- 3487US9260719B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2014·Granted Feb 16, 2016·8 cites·10 claims
- 3587US8476416B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesKANDIMALLA EKAMBAR R·Filed 2006·Granted Jul 2, 2013·6 cites·11 claims
- 3687US8106173B2Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8KANDIMALLA EKAMBAR R·Filed 2007·Granted Jan 31, 2012·9 cites·14 claims
- 3787US7851453B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Dec 14, 2010·17 cites·22 claims
- 3887US5614622A5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide synthesesHYBRIDON INC·Filed 1995·Granted Mar 25, 1997·95 cites·5 claims
- 3986US9243050B2Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8IDERA PHARMACEUTICALS INC·Filed 2014·Granted Jan 26, 2016·7 cites·20 claims
- 4086US9206430B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2012·Granted Dec 8, 2015·7 cites·14 claims
- 4186US8946175B1Stabilized immunomodulatory oligonucleotidesKANDIMALLA EKAMBAR R·Filed 2011·Granted Feb 3, 2015·5 cites·25 claims
- 4285US5962674ASynthesis of oligonucleotides containing alkylphosphonate internucleoside linkagesHYBRIDON INC·Filed 1996·Granted Oct 5, 1999·89 cites·2 claims
- 4384US6140482APrimary phosphoramidate internucleoside linkages and oligonucleotides containing the sameHYBRIDON INC·Filed 1995·Granted Oct 31, 2000·84 cites·6 claims
- 4483US5955599AProcess for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkagesHYBRIDON INC·Filed 1995·Granted Sep 21, 1999·83 cites·14 claims
- 4581US8759310B2Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8KANDIMALLA EKAMBAR R·Filed 2012·Granted Jun 24, 2014·4 cites·20 claims
- 4681US8420615B2Immunostimulatory oligonucleotide multimersAGRAWAL SUDHIR·Filed 2009·Granted Apr 16, 2013·3 cites·6 claims
- 4781US7851454B2Short immunomodulatory oligonucleotidesIDERA PHARMACEUTIALS INC·Filed 2007·Granted Dec 14, 2010·7 cites·8 claims
- 4880US8030462B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Oct 4, 2011·8 cites·7 claims
- 4980US7932367B2Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Apr 26, 2011·7 cites·4 claims
- 5079US8153777B2Modulation of toll-like receptor 5 expression by antisense oligonucleotidesKANDIMALLA EKAMBAR·Filed 2009·Granted Apr 10, 2012·3 cites·23 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dong Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →